A case-control study of genotoxicity endpoints in patients with papillary thyroid cancer

Ferlay, 2013 Bonassi, 2007, An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans, Carcinogenesis, 28, 625, 10.1093/carcin/bgl177 Kirsch-Volders, 2014, Commentary: critical questions, misconceptions and a road map for improving the use of the lymphocyte cytokinesis-block micronucleus assay for in vivo biomonitoring of human exposure to genotoxic chemicals-a HUMN project perspective, Mutat. Res. Rev. Mutat. Res., 759, 49, 10.1016/j.mrrev.2013.12.001 Collins, 2014, The comet assay as a tool for human biomonitoring studies: the ComNet project, Mutat. Res. Rev., 759, 27, 10.1016/j.mrrev.2013.10.001 Jung, 2013, Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010, Cancer Res. Treat., 45, 1, 10.4143/crt.2013.45.1.1 Xing, 2013, Molecular pathogenesis and mechanisms of thyroid cancer, Nat. Rev. Cancer, 13, 184, 10.1038/nrc3431 Nikiforov, 2008, Thyroid carcinoma: molecular pathways and therapeutic targets, Mod. Pathol., 21, S37, 10.1038/modpathol.2008.10 Sethi, 2010, Biomarkers for the diagnosis of thyroid cancer, J. Exp. Ther. Oncol., 8, 341 Fenech, 1985, Measurement of micronuclei in lymphocytes, Mutat. Res., 147, 29, 10.1016/0165-1161(85)90015-9 Kopjar, 2010, Normal and cut-off values of the cytokinesis-block micronucleus assay on peripheral blood lymphocytes in the Croatian general population, Arh. Hig. Rada. Toksikol., 61, 219, 10.2478/10004-1254-61-2010-2027 Fenech, 2007, Cytokinesis-block micronucleus cytome assay, Nat. Protoc., 2, 1084, 10.1038/nprot.2007.77 Singh, 1988, A simple technique for quantitation of low levels of DNA damage in individual cells, Exp. Cell Res., 175, 184, 10.1016/0014-4827(88)90265-0 Gerić, 2012, Cytogenetic status of human lymphocytes after exposure to low concentrations of p,p′-DDT, and its metabolites (p,p′-DDE, and p,p′-DDD) in vitro, Chemosphere, 87, 1288, 10.1016/j.chemosphere.2012.01.037 Grah, 2008, Immunohistochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features, Coll. Antropol., 32, 731 de Groot, 2006, RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors, Endocr. Rev., 27, 535, 10.1210/er.2006-0017 Kondo, 2007, Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas, Hum. Pathol., 38, 1810, 10.1016/j.humpath.2007.04.014 Iarmarcovai, 2008, Micronuclei frequency in peripheral blood lymphocytes of cancer patients: a meta-analysis, Mutat. Res., 659, 274, 10.1016/j.mrrev.2008.05.006 Catena, 2000, Micronucleus yield and colorimetric test as indicators of damage in patients’ lymphocytes after 131I therapy, J. Nucl. Med., 41, 1522 Monteiro-Gil, 2000, No evidence of increased chromosomal aberrations and micronuclei in lymphocytes from nonfamilial thyroid cancer patients prior to radiotherapy, Cancer Genet. Cytogenet., 123, 55, 10.1016/S0165-4608(00)00305-8 Fenech, 2003, HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures, Mutat. Res., 534, 65, 10.1016/S1383-5718(02)00249-8 Bonassi, 2011, Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies, Mutagenesis, 26, 93, 10.1093/mutage/geq075 García-Quispes, 2013, Influence of DNA-repair gene variants on the micronucleus frequency in thyroid cancer patients, Mutat. Res., 750, 34, 10.1016/j.mrgentox.2012.08.008 Fenech, 2011, Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells, Mutagenesis, 26, 125, 10.1093/mutage/geq052 Valverde, 2009, Environmental and occupational biomonitoring using the comet assay, Mutat. Res., 681, 93, 10.1016/j.mrrev.2008.11.001 García-Quispes, 2012, Possible role of the WDR3 gene on genome stability in thyroid cancer patients, PLoS One, 7, e44288, 10.1371/journal.pone.0044288 García-Quispes, 2013, Influence of DNA-repair gene variants on the micronucleus frequency in thyroid cancer patients, Mutat. Res., 750, 34, 10.1016/j.mrgentox.2012.08.008 Santos, 2010, Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women, Clin. Exp. Med., 10, 87, 10.1007/s10238-009-0079-4 Lou, 2007, Investigating the genetic instability in the peripheral lymphocytes of 36 untreated lung cancer patients with comet assay and micronucleus assay, Mutat. Res., 617, 104, 10.1016/j.mrfmmm.2007.01.004 Saran, 2008, Risk assessment of oral cancer in patients with pre-cancerous states of the oral cavity using micronucleus test and challenge assay, Oral. Oncol., 44, 354, 10.1016/j.oraloncology.2007.05.002 Ceppi, 2011, Study design and statistical analysis of data in human population studies with the micronucleus assay, Mutagenesis, 26, 247, 10.1093/mutage/geq060